HALOZYME THERAPEUTICS INC 4
4 · HALOZYME THERAPEUTICS INC · Filed Sep 16, 2013
Insider Transaction Report
Form 4
PATTON JOHN STUART
Director
Transactions
- Sale
Common Stock
2013-09-13$9.10/sh−37,500$341,359→ 192,500 total - Sale
Common Stock
2013-09-16$9.16/sh−37,500$343,680→ 155,000 total - Exercise/Conversion
Common Stock
2013-09-13$0.39/sh+100,000$39,000→ 230,000 total - Exercise/Conversion
Option to Purchase Common Stock (NSO)
2013-09-13$0.39/sh−100,000$39,000→ 0 totalExercise: $0.39From: 2004-12-09Exp: 2013-12-09→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.07 to $9.17. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares sold at each separate price.
- [F2]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.075 to $9.24. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares sold at each separate price.